210 related articles for article (PubMed ID: 17111435)
21. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
22. Cell culture models of transmissible spongiform encephalopathies.
Béranger F; Mangé A; Solassol J; Lehmann S
Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
[TBL] [Abstract][Full Text] [Related]
23. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
[TBL] [Abstract][Full Text] [Related]
24. New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.
Nicolas O; Gavín R; del Río JA
Brain Res Rev; 2009 Oct; 61(2):170-84. PubMed ID: 19523487
[TBL] [Abstract][Full Text] [Related]
25. Direct interaction between prion protein and tubulin.
Nieznanski K; Nieznanska H; Skowronek KJ; Osiecka KM; Stepkowski D
Biochem Biophys Res Commun; 2005 Aug; 334(2):403-11. PubMed ID: 16004966
[TBL] [Abstract][Full Text] [Related]
26. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
27. Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry.
Strom A; Diecke S; Hunsmann G; Stuke AW
Proteomics; 2006 Jan; 6(1):26-34. PubMed ID: 16294306
[TBL] [Abstract][Full Text] [Related]
28. Glycan chains modulate prion protein binding to immobilized metal ions.
Moudjou M; Bernard J; Sabuncu E; Langevin C; Laude H
Neurochem Int; 2007 Apr; 50(5):689-95. PubMed ID: 17293006
[TBL] [Abstract][Full Text] [Related]
29. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
30. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
31. The prion paradox: infection or polymerisation?
Biro JC
Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
[TBL] [Abstract][Full Text] [Related]
32. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns.
Mercey R; Lantier I; Maurel MC; Grosclaude J; Lantier F; Marc D
Arch Virol; 2006 Nov; 151(11):2197-214. PubMed ID: 16799875
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis.
Féraudet-Tarisse C; Andréoletti O; Morel N; Simon S; Lacroux C; Mathey J; Lamourette P; Relaño A; Torres JM; Créminon C; Grassi J
J Gen Virol; 2010 Jun; 91(Pt 6):1635-45. PubMed ID: 20107012
[TBL] [Abstract][Full Text] [Related]
34. Microglia and prion disease: a review.
Brown DR; Kretzschmar HA
Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
[TBL] [Abstract][Full Text] [Related]
35. Quantitative profiling of the pathological prion protein allotypes in bank voles by liquid chromatography-mass spectrometry.
Cartoni C; Schininà ME; Maras B; Nonno R; Vaccari G; Di Bari M; Conte M; De Pascalis A; Principe S; Cardone F; Pocchiari M; Agrimi U
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):302-6. PubMed ID: 17008136
[TBL] [Abstract][Full Text] [Related]
36. The neurochemical nature of PrP(c)-containing cells in the rat brain.
Moleres FJ; Velayos JL
Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
[TBL] [Abstract][Full Text] [Related]
37. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
38. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
40. Prion proteins: physiological functions and role in neurological disorders.
Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
